Bluejay Diagnostics Files 2024 Annual Report

Ticker: BJDX · Form: 10-K · Filed: 2025-03-31T00:00:00.000Z

Sentiment: neutral

Topics: annual-report, 10-K, medical-devices

TL;DR

Bluejay Diagnostics filed its 2024 10-K. All systems go for review.

AI Summary

Bluejay Diagnostics, Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2024. The company, incorporated in Delaware with its principal executive offices in Acton, MA, operates in the Surgical & Medical Instruments & Apparatus industry. The filing covers its operations and financial status as of March 31, 2025.

Why It Matters

This 10-K filing provides investors and stakeholders with a comprehensive overview of Bluejay Diagnostics' financial performance, business operations, and risk factors for the fiscal year 2024.

Risk Assessment

Risk Level: medium — As a medical device company, Bluejay Diagnostics faces inherent risks related to product development, regulatory approvals, market adoption, and competition.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Bluejay Diagnostics, Inc.?

Bluejay Diagnostics, Inc. operates in the Surgical & Medical Instruments & Apparatus industry, as indicated by its SIC code 3841.

When did Bluejay Diagnostics, Inc. file its annual report?

The company filed its Form 10-K on March 31, 2025.

For which fiscal year is this 10-K report?

This report is for the fiscal year ended December 31, 2024.

Where are Bluejay Diagnostics, Inc.'s principal executive offices located?

The principal executive offices are located at 360 Massachusetts Avenue, Suite 203, Acton, MA 01720.

What is the company's state of incorporation?

Bluejay Diagnostics, Inc. is incorporated in Delaware.

From the Filing

0001213900-25-026275.txt : 20250331 0001213900-25-026275.hdr.sgml : 20250331 20250331161827 ACCESSION NUMBER: 0001213900-25-026275 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 76 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250331 DATE AS OF CHANGE: 20250331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bluejay Diagnostics, Inc. CENTRAL INDEX KEY: 0001704287 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 473552922 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41031 FILM NUMBER: 25793523 BUSINESS ADDRESS: STREET 1: 360 MASSACHUSETTS AVENUE, SUITE 203 CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: (978) 631-0152 MAIL ADDRESS: STREET 1: 360 MASSACHUSETTS AVENUE, SUITE 203 CITY: ACTON STATE: MA ZIP: 01720 10-K 1 ea0234502-10k_bluejay.htm ANNUAL REPORT     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 10-K   (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   For the Fiscal Year Ended December 31 , 2024   Or   ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Commission file number: 001-41031   Bluejay Diagnostics, Inc.  (Exact Name of Registrant as Specified in Its Charter)   Delaware   47-3552922 (State or Other Jurisdiction of Incorporation or Organization)   (I.R.S. Employer Identification No.)   360 Massachusetts Avenue , Suite 203 , Acton , MA   01720 (Address of Principal Executive Offices)   (Zip Code)   (844) 327-7078 (Registrant’s Telephone Number, Including Area Code)     Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.0001 per share   BJDX   The Nasdaq Stock Market LLC   Securities registered pursuant to section 12(g) of the Act: None    Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐   No ☒     Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐   No ☒     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒    No ☐   Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒    No ☐   Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.   Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☒   If an emerging growth company, indicate by check mark if the regist

View on Read The Filing